These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38286485)

  • 1. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial.
    Zhang X; Jing J; Wang A; Xie X; Johnston SC; Li H; Bath PM; Xu Q; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Chen W; Gong X; Li J; Han X; Meng X; Wang Y
    Stroke Vasc Neurol; 2024 Nov; 9(5):541-550. PubMed ID: 38286485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of dual antiplatelet therapy after ischemic stroke according to hsCRP levels and CYP2C19 genotype.
    Yang M; Xu J; Xue J; Pan Y; Cheng A; Gao F; Meng X; Miao Z; Wang Y; Wang Y;
    Am Heart J; 2025 Feb; 280():89-97. PubMed ID: 39536847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of Dyspnea after Ticagrelor Treatment and the Effect of Switching to Clopidogrel in Patients with Myocardial Infarction.
    Kim SH; Shin S; Choo EH; Choi IJ; Lim S; Moon D; Kim CJ; Park MW; Kim MC; Hwang BH; Lee KY; Choi YS; Kim HY; Yoo KD; Jeon DS; Ahn Y; Chang K;
    Thromb Haemost; 2024 Dec; 124(12):1152-1161. PubMed ID: 38574757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of early versus delayed acetylsalicylic acid after surgery for spontaneous intracerebral haemorrhage in China (E-start): a prospective, multicentre, open-label, blinded-endpoint, randomised trial.
    Liu Q; Mo S; Wu J; Tong X; Wang K; Chen X; Chen S; Guo S; Li X; Li M; Peng L; Sun X; Wang Y; Sun J; Pu J; Zheng K; Zhang J; Liu Y; Yang Y; Wen Z; Nie X; Feng Y; Lan C; Tang H; Wang N; Li J; Miao Z; Lu X; Ning B; Zhao B; Kang D; Chen X; Zhang Y; Zhang Y; Wang A; Zhu C; Araki Y; Uda K; Yoshimura S; Uchida K; Morimoto T; Yoshioka H; Hasan D; Du R; Levitt MR; Cao Y; Wang S; Zhao J;
    Lancet Neurol; 2024 Dec; 23(12):1195-1204. PubMed ID: 39577920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis.
    Carvalho PEP; Gewehr DM; Nascimento BR; Melo L; Burkhardt G; Rivera A; Braga MAP; Guimarães PO; Mehran R; Windecker S; Valgimigli M; Angiolillo DJ; Bhatt DL; Sandoval Y; Chen SL; Stone GW; Lopes RD
    JAMA Cardiol; 2024 Dec; 9(12):1094-1105. PubMed ID: 39382876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation.
    Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D
    Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack.
    De Matteis E; Ornello R; De Santis F; Foschi M; Romoli M; Tassinari T; Saia V; Cenciarelli S; Bedetti C; Padiglioni C; Censori B; Puglisi V; Vinciguerra L; Guarino M; Barone V; Zedde M; Grisendi I; Diomedi M; Bagnato MR; Petruzzellis M; Mezzapesa DM; Di Viesti P; Inchingolo V; Cappellari M; Zenorini M; Candelaresi P; Andreone V; Rinaldi G; Bavaro A; Cavallini A; Moraru S; Querzani P; Terruso V; Mannino M; Pezzini A; Frisullo G; Muscia F; Paciaroni M; Mosconi MG; Zini A; Leone R; Palmieri C; Cupini LM; Marcon M; Tassi R; Sanzaro E; Paci C; Viticchi G; Orsucci D; Falcou A; Diamanti S; Tarletti R; Nencini P; Rota E; Sepe FN; Ferrandi D; Caputi L; Volpi G; Spada S; Beccia M; Rinaldi C; Mastrangelo V; Di Blasio F; Invernizzi P; Pelliccioni G; De Angelis MV; Bonanni L; Ruzza G; Caggia EA; Russo M; Tonon A; Acciarri MC; Anticoli S; Roberti C; Manobianca G; Scaglione G; Pistoia F; Fortini A; De Boni A; Sanna A; Chiti A; Barbarini L; Caggiula M; Masato M; Del Sette M; Passarelli F; Roberta Bongioanni M; Toni D; Ricci S; Sacco S
    Eur Stroke J; 2024 Dec; 9(4):989-999. PubMed ID: 38869034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis.
    Maas DPMSM; Willems LH; Kranendonk J; Kramers C; Warlé MC
    Drugs; 2024 Oct; 84(10):1275-1297. PubMed ID: 39235670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
    Filippini G; Del Giovane C; Vacchi L; D'Amico R; Di Pietrantonj C; Beecher D; Salanti G
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD008933. PubMed ID: 23744561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost effectiveness of genetic testing for CYP2C19 variants to guide thienopyridine treatment in patients with acute coronary syndromes: a New Zealand evaluation.
    Panattoni L; Brown PM; Te Ao B; Webster M; Gladding P
    Pharmacoeconomics; 2012 Nov; 30(11):1067-84. PubMed ID: 22974536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.
    Desborough MJR; Al-Shahi Salman R; Stanworth SJ; Havard D; Woodhouse LJ; Craig J; Krishnan K; Brennan PM; Dineen RA; Coats TJ; Hepburn T; Bath PM; Sprigg N;
    Lancet Neurol; 2023 Jul; 22(7):557-567. PubMed ID: 37353276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-Dose Antiplatelet Dual Combination in Patients with Coronary Artery Disease in Turkish Population: DAPT-TR.
    Öz A; Toprak K; Aydin E; Saraç İ; Doğduş M; Opan S; Yenerçağ M; Tascanov MB; Kümet Ö; Karaağaç M; Özmen M; Murat B; Kertmen Ö; Bekler Ö; İnci S; Huyut MA; Özderya A; Er F; Duran M; Ardahanlı İ; Baş MM; Güzel T; Ceyhun G; Özdemir İH; Özen MB; Gündüz R; Erdoğan A; Çetin İ; Barış VÖ; Yayla Ç; Karaduman M; Aşkın L; Bekar L; Tanrıverdi O; Özkan E; Yeşil E; Çalışkan S; Kuzu Z; Uğuz B; Böyük F; Kunak AÜ; Murat S; Asil S; Kayhan Ö; Erdoğan E; Duz R; Katkat F; Ekin T; İbişoğlu E; Ateş BN; Ayça B; Ergene AO; Zoghi M
    Arq Bras Cardiol; 2024 Oct; 121(11):e20240202. PubMed ID: 39607170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.
    Sheth KN; Albers GW; Saver JL; Campbell BCV; Molyneaux BJ; Hinson HE; Cordonnier C; Steiner T; Toyoda K; Wintermark M; Littauer R; Collins J; Lucas N; Nogueira RG; Simard JM; Wald M; Dawson K; Kimberly WT;
    Lancet Neurol; 2024 Dec; 23(12):1205-1213. PubMed ID: 39577921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort.
    Foschi M; D'Anna L; De Matteis E; De Santis F; Romoli M; Tassinari T; Saia V; Cenciarelli S; Bedetti C; Padiglioni C; Censori B; Puglisi V; Vinciguerra L; Guarino M; Barone V; Zedde M; Grisendi I; Diomedi M; Bagnato MR; Petruzzellis M; Mezzapesa DM; Di Viesti P; Inchingolo V; Cappellari M; Zivelonghi C; Candelaresi P; Andreone V; Rinaldi G; Bavaro A; Cavallini A; Moraru S; Piscaglia MG; Terruso V; Mannino M; Pezzini A; Frisullo G; Muscia F; Paciaroni M; Mosconi MG; Zini A; Leone R; Palmieri C; Cupini LM; Marcon M; Tassi R; Sanzaro E; Papiri G; Paci C; Viticchi G; Orsucci D; Falcou A; Beretta S; Tarletti R; Nencini P; Rota E; Sepe FN; Ferrandi D; Caputi L; Volpi G; La Spada S; Beccia M; Rinaldi C; Mastrangelo V; Di Blasio F; Invernizzi P; Pelliccioni G; De Angelis MV; Bonanni L; Ruzza G; Caggia EA; Russo M; Tonon A; Acciarri MC; Anticoli S; Roberti C; Manobianca G; Scaglione G; Pistoia F; Fortini A; De Boni A; Sanna A; Chiti A; Barbarini L; Caggiula M; Masato M; Del Sette M; Passarelli F; Bongioanni MR; De Michele M; Ricci S; Ornello R; Sacco S;
    Stroke; 2024 Dec; ():. PubMed ID: 39648888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and Design of Dual Antiplatelet Therapy in Patients with Coronary Multi-Vessel Disease (DAPT-MVD): A Multicenter, Randomized, Controlled Trial.
    Tian J; Wang Z; Wang Y; Wang F; Wang Y; Zhao P; Hou X; Peng X; Tian M; Wang D; Yu B
    Clin Cardiol; 2024 Dec; 47(12):e70049. PubMed ID: 39587825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
    Sridhar S; Joaquin A; Bonaparte MI; Bueso A; Chabanon AL; Chen A; Chicz RM; Diemert D; Essink BJ; Fu B; Grunenberg NA; Janosczyk H; Keefer MC; Rivera M DM; Meng Y; Michael NL; Munsiff SS; Ogbuagu O; Raabe VN; Severance R; Rivas E; Romanyak N; Rouphael NG; Schuerman L; Sher LD; Walsh SR; White J; von Barbier D; de Bruyn G; Canter R; Grillet MH; Keshtkar-Jahromi M; Koutsoukos M; Lopez D; Masotti R; Mendoza S; Moreau C; Ceregido MA; Ramirez S; Said A; Tavares-Da-Silva F; Shi J; Tong T; Treanor J; Diazgranados CA; Savarino S
    Lancet Infect Dis; 2022 May; 22(5):636-648. PubMed ID: 35090638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.